Vifor Pharma AG
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vifor Pharma AG's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7% to $1,824,600,000. Profit margin reached 15%. Total operating expenses were $796,600,000.
Profit Margin
| 2012 | 3.29B | 253.46M | 7.69% |
|---|---|---|---|
| 2013 | 3.35B | 296.16M | 8.82% |
| 2014 | 3.41B | 284.45M | 8.33% |
| 2015 | 3.79B | 301.06M | 7.94% |
| 2016 | 4.11B | 243.62M | 5.92% |
| 2017 | 1.34B | 1.14B | 85.47% |
| 2018 | 1.58B | 152.4M | 9.62% |
| 2019 | 1.87B | 159.1M | 8.47% |
| 2020 | 1.70B | 359.6M | 21.08% |
| 2021 | 1.82B | 265.4M | 14.55% |
GNHAY Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.82B | 1.70B | 1.87B | 1.58B | 1.34B | 4.11B | 3.79B | 3.41B | 3.35B | 3.29B |
Cost of revenue | 671.8M | 701.2M | 761.5M | 648.7M | 517.9M | 2.47B | 2.33B | 2.17B | 2.16B | 2.13B |
Gross profit | 1.15B | 1.00B | 1.11B | 936M | 824.2M | 1.63B | 1.46B | 1.23B | 1.18B | 1.15B |
Operating exp. | ||||||||||
Research and development | 252.7M | 250M | 228.3M | 206.4M | 185.1M | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 399.2M | 403.8M | 455.3M | 410.8M | 434M | 173.79M | 148.81M | 140.52M | 136.65M | 133.97M |
Total operating expenses | 796.6M | 744.1M | 790.9M | 708.5M | 689.9M | 1.28B | 1.01B | 877.58M | 806.17M | 818.34M |
Operating income | 199.7M | 260.3M | 325M | 227.5M | 134.3M | 356.23M | 445.83M | 360.92M | 383.56M | 337.34M |
Other income (expenses), net | 112M | 4.4M | -15.4M | 41.9M | -8.7M | -20.70M | -16.85M | -3.64M | -20.30M | -16.17M |
Income before tax | 311.7M | 264.7M | 309.6M | 269.4M | 125.6M | 335.53M | 428.97M | 357.27M | 363.26M | 321.16M |
Income tax expense | 46.3M | 27.1M | 35.9M | 25M | 1.6M | 11.76M | 58.97M | 45.28M | 28.41M | 46.36M |
Net income | 265.4M | 359.6M | 159.1M | 152.4M | 1.14B | 243.62M | 301.06M | 284.45M | 296.16M | 253.46M |
Earnings per share | ||||||||||
Basic EPS | 0.82 | 1.11 | 0.49 | 0.47 | 3.54 | 0.75 | 0.93 | 0.88 | 0.91 | 0.78 |
Diluted EPS | 0.82 | 1.11 | 0.49 | 0.47 | 3.53 | 0.75 | 0.93 | 0.88 | 0.91 | 0.78 |